139 related articles for article (PubMed ID: 19738069)
1. Role of cyclic AMP response element-binding protein in insulin-like growth factor-i receptor up-regulation by sex steroids in prostate cancer cells.
Genua M; Pandini G; Sisci D; Castoria G; Maggiolini M; Vigneri R; Belfiore A
Cancer Res; 2009 Sep; 69(18):7270-7. PubMed ID: 19738069
[TBL] [Abstract][Full Text] [Related]
2. 17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells.
Pandini G; Genua M; Frasca F; Squatrito S; Vigneri R; Belfiore A
Cancer Res; 2007 Sep; 67(18):8932-41. PubMed ID: 17875736
[TBL] [Abstract][Full Text] [Related]
3. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
[TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits androgen-induced IGF-IR up-regulation in prostate cancer cells by disrupting membrane-initiated androgen signaling.
Malaguarnera R; Sacco A; Morcavallo A; Squatrito S; Migliaccio A; Morrione A; Maggiolini M; Belfiore A
Endocrinology; 2014 Apr; 155(4):1207-21. PubMed ID: 24437490
[TBL] [Abstract][Full Text] [Related]
5. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
Arnold JT; Le H; McFann KK; Blackman MR
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
[TBL] [Abstract][Full Text] [Related]
7. Sex steroids upregulate the IGF-1R in prostate cancer cells through a nongenotropic pathway.
Pandini G; Genua M; Frasca F; Vigneri R; Belfiore A
Ann N Y Acad Sci; 2009 Feb; 1155():263-7. PubMed ID: 19250214
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ
J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
[TBL] [Abstract][Full Text] [Related]
10. Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type 2 diabetic mesangial cells.
Karl M; Potier M; Schulman IH; Rivera A; Werner H; Fornoni A; Elliot SJ
Endocrinology; 2005 Feb; 146(2):889-900. PubMed ID: 15550505
[TBL] [Abstract][Full Text] [Related]
11. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ
Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
[TBL] [Abstract][Full Text] [Related]
12. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA.
Dai JL; Burnstein KL
Mol Endocrinol; 1996 Dec; 10(12):1582-94. PubMed ID: 8961268
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells.
Damon SE; Plymate SR; Carroll JM; Sprenger CC; Dechsukhum C; Ware JL; Roberts CT
Endocrinology; 2001 Jan; 142(1):21-7. PubMed ID: 11145562
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of insulin-like growth factor-I receptor gene expression by wild type and mutant androgen receptor in prostate cancer cells.
Schayek H; Seti H; Greenberg NM; Sun S; Werner H; Plymate SR
Mol Cell Endocrinol; 2010 Jul; 323(2):239-45. PubMed ID: 20417685
[TBL] [Abstract][Full Text] [Related]
15. Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
Wu JD; Haugk K; Woodke L; Nelson P; Coleman I; Plymate SR
J Cell Biochem; 2006 Oct; 99(2):392-401. PubMed ID: 16639715
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor alpha (ERalpha) and insulin-like growth factor I receptor (IGF-IR) cross-talk in the gonadotropic alphaT3-1 cell line.
Eertmans F; Dhooge W; De Wever O; Bracke M; Comhaire F; Kaufman JM
J Cell Physiol; 2007 Sep; 212(3):583-90. PubMed ID: 17458895
[TBL] [Abstract][Full Text] [Related]
17. Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model.
Krueckl SL; Sikes RA; Edlund NM; Bell RH; Hurtado-Coll A; Fazli L; Gleave ME; Cox ME
Cancer Res; 2004 Dec; 64(23):8620-9. PubMed ID: 15574769
[TBL] [Abstract][Full Text] [Related]
18. In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR).
Nickerson T; Chang F; Lorimer D; Smeekens SP; Sawyers CL; Pollak M
Cancer Res; 2001 Aug; 61(16):6276-80. PubMed ID: 11507082
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner.
Schayek H; Haugk K; Sun S; True LD; Plymate SR; Werner H
Clin Cancer Res; 2009 Mar; 15(5):1558-65. PubMed ID: 19223505
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
Knowlden JM; Hutcheson IR; Barrow D; Gee JM; Nicholson RI
Endocrinology; 2005 Nov; 146(11):4609-18. PubMed ID: 16037379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
